Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope
dc.contributor.author | Ling, Song | en_US |
dc.contributor.author | Lai, Angela | en_US |
dc.contributor.author | Borschukova, Olga | en_US |
dc.contributor.author | Pumpens, Paul | en_US |
dc.contributor.author | Holoshitz, Joseph | en_US |
dc.date.accessioned | 2007-09-20T17:49:24Z | |
dc.date.available | 2008-01-03T16:21:01Z | en_US |
dc.date.issued | 2006-11 | en_US |
dc.identifier.citation | Ling, Song; Lai, Angela; Borschukova, Olga; Pumpens, Paul; Holoshitz, Joseph (2006). "Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope." Arthritis & Rheumatism 54(11): 3423-3432. <http://hdl.handle.net/2027.42/55859> | en_US |
dc.identifier.issn | 0004-3591 | en_US |
dc.identifier.issn | 1529-0131 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/55859 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17075829&dopt=citation | en_US |
dc.description.abstract | Objective Susceptibility to rheumatoid arthritis (RA) is closely associated with HLA–DRB1 alleles encoding a shared epitope (SE) in positions 70–74 of the HLA–DRΒ chain. The mechanistic basis for this association is unknown. Given the proposed pathogenic role of nitric oxide (NO) in RA, this study was undertaken to examine whether the SE can trigger NO signaling events. Methods The intracellular levels of NO were measured with the fluorescent NO probe 4,5-diaminofluorescein diacetate and by the 2,3-diaminonaphthalene method. NO synthase activity was determined by measuring the rate of conversion of radioactive arginine to citrulline. Levels of cGMP were measured with a commercial enzyme-linked immunosorbent assay, and the cytolytic activity of T cells was measured using a standard 51 Cr release assay. Results Lymphoblastoid B cell lines carrying SE-positive HLA–DR alleles displayed a higher rate of spontaneous NO production compared with SE-negative cells. L cell transfectants expressing SE-positive DR molecules on their surface also generated higher levels of NO. Tetrameric HLA–DR molecules containing a DRΒ-chain encoded by the SE-positive DRB1*0401 allele stimulated fibroblast cells to produce higher levels of NO compared with cells stimulated with a control HLA–DR tetramer. Multimeric hepatitis B core proteins engineered to express region 65–79 encoded by the DRB1*0401 allele, but not the same region encoded by the control allele DRB1*0402 , stimulated NO production in fibroblasts. Similarly, synthetic 15-mer peptides corresponding to the region 65–79 encoded by SE-positive alleles triggered increased NO levels when incubated with class II major histocompatibility complex–negative cells. The signaling pathway was found to involve NO synthase activation, followed by increased production of cGMP. SE-triggered increased NO levels inhibited cytolytic elimination of target cells. Conclusion The SE can trigger NO-mediated signaling events in opposite cells, and may thereby contribute to RA pathogenesis. | en_US |
dc.format.extent | 399282 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.title | Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Geriatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor ; Drs. Ling and Holoshitz have a US patent for USPTO 7,074,893. | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor ; Dr. Holoshitz receives licensing fees for an unrelated technology from Protein Design Laboratories through the Stanford Technology Office. ; Department of Internal Medicine, University of Michigan, 1150 West Medical Center Drive, 5520 MSRB I, Ann Arbor, MI 48109-0680 | en_US |
dc.contributor.affiliationother | Biomedical Research and Study Center, University of Latvia, Riga, Latvia | en_US |
dc.contributor.affiliationother | Biomedical Research and Study Center, University of Latvia, Riga, Latvia | en_US |
dc.identifier.pmid | 17075829 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/55859/1/22178_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/art.22178 | en_US |
dc.identifier.source | Arthritis & Rheumatism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.